Dydrogesterone
- Generic Name
- Dydrogesterone
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O2
- CAS Number
- 152-62-5
- Unique Ingredient Identifier
- 90I02KLE8K
- Background
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation.
- Indication
Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.
- Associated Conditions
- Infertility, Menstrual Distress (Dysmenorrhea), Premenstrual Syndrome (PMS), Recurrent Miscarriages, Spontaneous Abortions
- Associated Therapies
- Assisted Reproductive Technology therapy, Menstrual Regulation
Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Abbott
- Target Recruit Count
- 250
- Registration Number
- NCT06952296
PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial
- Conditions
- PPOSGnRH AntagonistAssisted Reproductive Techniques
- Interventions
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Kasr El Aini Hospital
- Target Recruit Count
- 328
- Registration Number
- NCT06868576
- Locations
- 🇪🇬
Ciro University Kasr Alainy OBGYN Hospital, Cairo, Alquahira, Egypt
Non-surgical Interventions for Infertility in Endometriosis
- Conditions
- Infertility, FemaleEndometriosis
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Target Recruit Count
- 18
- Registration Number
- NCT06560814
- Locations
- 🇧🇩
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)
- Conditions
- Progestins Primed Ovarian Stimulation
- Interventions
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Mỹ Đức Hospital
- Target Recruit Count
- 626
- Registration Number
- NCT06378268
- Locations
- 🇻🇳
My Duc Hospital, Ho Chi Minh City, Vietnam
Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes
- Conditions
- IVF
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 387
- Registration Number
- NCT05972902
- Locations
- 🇪🇬
Beni-suef university Hospital, Banī Suwayf, Beni Suef, Egypt
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 200
- Registration Number
- NCT05951400
- Locations
- 🇪🇬
Beni-suef university Hospital, Banī Suwayf, Beni Suef, Egypt
Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles
- Conditions
- Infertility
- Interventions
- Drug: Gonadotropin releasing hormone antagonist (Cetrotide)
- First Posted Date
- 2023-03-14
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Bezmialem Vakif University
- Target Recruit Count
- 297
- Registration Number
- NCT05767086
- Locations
- 🇹🇷
Bezmialem Vakif University, Istanbul, Turkey
The Rescue of Hormonal Replacement Frozen Embryo Transfer Cycle With Low Serum Progesterone.
- Conditions
- Hormonal Replacement Frozen Embryo Transfer Cycle
- Interventions
- Drug: prolutex
- First Posted Date
- 2023-03-07
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- El Shatby University Hospital for Obstetrics and Gynecology
- Target Recruit Count
- 120
- Registration Number
- NCT05758064
- Locations
- 🇪🇬
Elshatby University Maternity Hospital, Alexandria, Egypt
🇪🇬Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
- Conditions
- Fertility IssuesOvary Cyst
- Interventions
- Other: progestin primed ovarian stimulation protocol
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 79
- Registration Number
- NCT05751681
- Locations
- 🇪🇬
Zagazig University, Zagazig, Egypt
DYG Versus Cetrorelix in Oocyte Donation
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Clinica de la Mujer Medicina Reproductiva, Chile
- Target Recruit Count
- 202
- Registration Number
- NCT05577806
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.